Sumedha Gupta
@drsumedhagupta.bsky.social
Expansion is often framed as a yes/no choice. Our findings suggest it’s more nuanced; policy context & implementation shape whether coverage translates into evidence-based care.
Grateful to my coauthors and collaborators. More to come as we continue examining how Medicaid design influences access.
Grateful to my coauthors and collaborators. More to come as we continue examining how Medicaid design influences access.
New @jamanetworkopen.com: Recent Medicaid expansions showed significant all-payer buprenorphine treatment increases while earlier expansions did not - suggesting current policy environment enhances effectiveness
With @drsumedhagupta.bsky.social, Kosali Simon, & team doi.org/10.1001/jama...
With @drsumedhagupta.bsky.social, Kosali Simon, & team doi.org/10.1001/jama...
Early vs Recent Medicaid Expansion and Buprenorphine Dispensing
This cross-sectional study evaluates the association of Medicaid expansion with buprenorphine treatment rates and tests whether post-2018 expansions differed from earlier ones.
jamanetwork.com
February 20, 2026 at 10:33 PM
Expansion is often framed as a yes/no choice. Our findings suggest it’s more nuanced; policy context & implementation shape whether coverage translates into evidence-based care.
Grateful to my coauthors and collaborators. More to come as we continue examining how Medicaid design influences access.
Grateful to my coauthors and collaborators. More to come as we continue examining how Medicaid design influences access.
Reposted by Sumedha Gupta
New paper - Medicaid "unwinding" associated with net decrease in buprenorphine prescribing for opioid use disorder (some offset from commercial insurance).
Some state policies mitigated this negative impact.
Hats off to @drsumedhagupta.bsky.social for this work!
jamanetwork.com/journals/jam...
Some state policies mitigated this negative impact.
Hats off to @drsumedhagupta.bsky.social for this work!
jamanetwork.com/journals/jam...
Trends in Access to Medications for Opioid Use Disorder
This cross-sectional study examines the association between Medicaid unwinding and dispensing of prescription buprenorphine, overall and by payment sources nationally and by state.
jamanetwork.com
April 8, 2025 at 3:47 PM
New paper - Medicaid "unwinding" associated with net decrease in buprenorphine prescribing for opioid use disorder (some offset from commercial insurance).
Some state policies mitigated this negative impact.
Hats off to @drsumedhagupta.bsky.social for this work!
jamanetwork.com/journals/jam...
Some state policies mitigated this negative impact.
Hats off to @drsumedhagupta.bsky.social for this work!
jamanetwork.com/journals/jam...
New in @Health_Affairs: Christopher Behrer, Velda Wang, Jessica Banthin, @KateBundorf & I find post-unwinding Medicaid redeterminations led to minimal changes in overall uninsurance as many offset Medicaid loss with employer-sponsored or private insurance.@IUImpact @IUNewsroom
www.healthaffairs.org
October 24, 2024 at 6:42 PM
New in @Health_Affairs: Christopher Behrer, Velda Wang, Jessica Banthin, @KateBundorf & I find post-unwinding Medicaid redeterminations led to minimal changes in overall uninsurance as many offset Medicaid loss with employer-sponsored or private insurance.@IUImpact @IUNewsroom